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Effect of Methylene Chloride Inhalation on
Replicative DNA Synthesis in the Lungs of
Female B6C3F Mice
by Jun Kanno1, Julie F. Foley2, F. Kari2, M. W. Anderson2,
and Robert R. Maronpot2
In the National Toxicology Program 2-year inhalation study ofdichloromethane (DCM), there
was a significant increase in pulmonary neoplasms in female B6C3F, mice exposed to 2000 ppm
(overall rates of30/48 versus 5/50 in control). Replicative DNA synthesis was examined to evalu-
ate the potential role oftreatment-induced lung cell proliferation on pulmonary carcinogenici-
ty. Tritiated thymidine incorporation was assessed in methacrylate plastic sections after 1, 2, 3,
or 4 weeks of inhalation exposure to 2000 ppm or 8000 ppm DCM. Similar measurements of
labeling indexes were made after 13 and 26 weeks of exposure to 2000 ppm DCM using bromo-
deoxyuridine as the labeling agent. In all cases the labeling agent was delivered over a 6-day
period using osmotic minipumps. The labeling index (LI) of bronchiolar epithelium (two
branches proximal to the terminal bronchiole) ofmice exposed to 2000 ppm DCM for 2-26 weeks
decreased to 4040% ofthe control. Terminal bronchioles showed a similar decrease in LI. Mice
exposed to 8000 ppm DCM had a less dramatic decrease in LI. No pathological change was
found in the exposed lungs. It is concluded that inhalation exposure to DCM for up to 26 weeks
reduces cell turnover ofbronchiolar cells in female B6C3F, mice.
Introduction
Dichloromethane (DCM; synonym, methylene chlo-
ride), an industrially and commercially important
chemical, was carcinogenic in mouse liver and lung in
2-year inhalation studies (1). Although DCM was
mutagenic for bacteria in the presence or absence of
liver microsomes (2), previous assays for genetic dam-
age in mammalian cells have provided conflicting
results (3). Initial reports of short-term in vivo assays
included failure to induce micronuclei in mouse bone
marrow, absence of covalent binding to mouse liver
DNA, and negative results in the in vivo/in vitro
unscheduled DNA synthesis assay (4). More recently,
inhalation of 4000 or 8000 ppm DCM for 10 days by
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B6C3F1 mice was reported to increase the frequency
ofsister chromatid exchanges in lung cells and lympho-
cytes and the frequency ofmicronuclei in erythrocytes
(3). After 3 months ofinhalation exposure to 2000 ppm
DCM, B6C3F1 mice had increases in lung cell sister
chromatid exchanges and erythrocyte micronuclei (3).
These recent findings support the contention that
DCM may induce lung tumors by a genotoxic mecha-
nism. This possibility is further supported by the
observation that some lung tumors in DCM-exposed
mice have point mutations in activated K-ras onco-
genes (5). In contrast, liver tumors induced by expo-
sure to DCM contained mutations in H-ras genes that
were typical of what was observed in spontaneous
liver tumors (5). Cell proliferation in the liver is
reported elsewhere (6).
Cell proliferation is known to play an important role
in the induction of neoplasia by both genotoxic and
nongenotoxic carcinogens (7). To determine whether
inhalation exposure to DCM was associated with alter-
ations in cell proliferation in the lung, osmotic
minipumps were used to label cells undergoing replica-
tive DNA synthesis over a 6-day period. Treatment-
related changes in cell turnover in lung were assessed
by determining the labeling index for bronchiolar and
alveolar cells.KANNO ETAL.
Materials and Methods
The chemical source of DCM and vapor generation
methodology for inhalation exposure are described in
detail elsewhere (8). A 30 mg/mL solution of bromod-
eoxyuridine (BrdU, Sigma Company, St. Louis, MO)
was prepared in phosphate-buffered saline containing
0.1 N NaOH. Tritiated thymidine was purchased from
DuPont (Boston, MA).
Two studies were conducted in series in which
female B6C3F1 mice were exposed to 2000 ppm or 8000
ppm of DCM (Fig. 1). In experiment A, 4- to 6-week-
old mice were exposed to air containing DCM at con-
centrations of0, 2000, or 8000 ppm, 6 hr per day, 5 days
per week for up to 4 weeks. Interim sacrifices were
done after 1, 2, 3, and 4 weeks of DCM exposure (Fig.
1). Each group consisted of five animals per exposure
concentration. Six days before sacrifice, osmotic
minipumps (Model 2001, Alzet Corporation, Palo Alto,
CA) containing 200 pL oftritiated thymidine (1.0 mCi/
mL) were implanted subcutaneously (9). The radioiso-
tope was delivered at a rate of 1 pL/hr. All mice were
killed by carbon dioxide asphyxiation, weighed, and
necropsied. Lungs were inflated with 10% buffered
formalin through the trachea and then immersed in
10% buffered formalin. Left, right apical, and right
diaphragmatic lobes were sectioned into halves along
the lobar bronchi, and each half was separately embed-
ded in methacrylate plastic; 2-pm sections were cut for
autoradiography and hematoxylin and eosin staining.
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FIGURE 1. Experimental design ofdichloromethane studies.
Selected blocks were sectioned and stained using the
alcian blue-periodic acid Schiff (AB-PAS) reaction for
detection of mucous metaplasia in the epithelium.
Standard autoradiographic labeling techniques were
used to detect cells that incorporated tritiated thymi-
dine. The slides were dipped in NBT2 emulsion
(Eastman Kodak, Rochester, NY), exposed for 12
weeks, developed, and counterstained with hema-
toxylin and eosin. Cells with 10 or more silver grains
over the nucleus were counted as labeled under high
power (400X) microscopic fields ofview.
In experiment B, 4- to 6-week-old mice were exposed
to air containing DCM at concentrations of 0 and 2000
ppm, 6 hr per day, 5 days per week for up to 78 weeks.
Interim sacrifices were done after 13, 26, 52, or 78
weeks of DCM exposure. Each group consisted of 10
animals per exposure concentration. Materials from
the 13-week and 26-week sacrifices were used for this
study. Six days before sacrifice, osmotic minipumps
(Model 2001, Alzet Corporation, Palo Alto, CA) con-
taining 200 pL of bromodeoxyuridine (BrdU) were
implanted subcutaneously (9). The labeling agent was
delivered at a rate of 1 pL/hr.
Methacrylate plastic sections of the lungs were pre-
pared as described for experiment A. Two-micrometer
sections were cut, and BrdU incorporation was identi-
fied by a modified immunohistochemical method using
anti-BrdU antibody and AEC (aminoethyl carbazole)
chromogen (10,11); tissues were counterstained with
hematoxylin. Selected blocks were sectioned and
stained usingthe AB-PAS reaction.
Epithelium of bronchioles that were two branches
proximal to the terminal bronchiole was counted to
generate labeling index (LI) data for bronchiolar
epithelium. About 100 epithelial cells per mouse were
counted. In addition, on the average, 200 epithelial
cells from terminal bronchioles were counted per
mouse for LI. Relative LI to control was calculated as
the ratio ofLI to the concurrent control value. Alveolar
duct cells and cells associated with a possible bronchi-
olization ofalveoli were not included as terminal bron-
chiQlar cells. Ciliated and nonciliated cells were distin-
guished in sections from experiment A. Ciliated and
non-ciliated cells were not distinguished in terminal
bronchioles in either experiment.
Statistical comparisons between treated and control
groups were performed using Student's t-test.
Results
Study results from experiments A and B are com-
bined and presented according to two anatomical sites
in the lungs.
es of the bronchiolar epithelium (two
al to the terminal bronchiole) in mice
ppm DCM from week 2 to week 26
4
lI_ Ltb lllalalu
1 (2000 ppm) Bronchioles
I;,,e BrdU by
minipump Labeling index hIranehbu nroximn
I r.. nrm inhnInfind
INN
272
li
immi
L-I.I.I.Ill.%%%%j
BB
I romInoI
ft
ML IJL U,%Illlc
exposed to 2000EFFECT OF METHYLENE INHALATION ONMOUSE LUNG
were significantly decreased compared to concurrent
controls. Mice exposed to 8000 ppm DCM had a slight
decrease in Lls from week 2 to 4 (Fig. 2). No treat-
ment-related cytomorphological changes in either cili-
ated or non-ciliated bronchiolar cells were observed.
AB-PAS staining showed no treatment-related increase
or decrease in mucus-containing cells in the bronchi-
oles. There were no significant changes in the ratio of
ciliated to non-ciliated bronchial cells during the 4
weeks oftreatment.
Terminal Bronchioles
Labeling indexes ofthe terminal bronchiolar epitheli-
um in mice exposed to 2000 ppm DCM were significant-
ly decreased compared to concurrent controls from
week 3 of exposure up to week 26. Mice exposed to
8000 ppm DCM had a marked decrease in LI in week 2
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and slight decrease in weeks 3 and 4 (Fig. 3). There
were no treatment-related morphological changes in
the terminal bronchioles. No AB-PAS positive bronchi-
olar cells were observed in treated and control animals.
Discussion
A 6-day continuous labeling protocol with osmotic
mini-pumps was used in this study to detect alter-
ations in cell proliferation in the lung (9). Under these
experimental conditions we observed 30 to 50% LI in
bronchiolar epithelium of control mice during the first
4 weeks of the study, and 20% LI in bronchiolar
epithelium of control mice during weeks 13-26. These
Lls are compatible with those of young growing and
nongrowing adult mice (12,13). On the other hand, a
40%-60% decrease in LI of the bronchiolar epithelium
ofDCM-exposed mice was observed for 2-26 weeks.
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FIGURE 2. Labeling index (LI) of epithelium of bronchioles two branches proximal to the terminal bronchiole obtained by 6-day continuous
labeling by osmotic minipump (top; mean ± sd) and the relative LI to control (bottom). (**) p < 0.01, (*) p < 0.05 by t-test compared to control.
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FIGURE 3. Labeling index (LI) of epithelium ofterminal bronchioles by 6-day continuous labeling by osmotic minipump (top; mean ± SD) and
the relative LI to control (bottom). (**) p < 0.01 by t-test compared to control.
The LI data obtained by a 6-day continuous labeling
technique are a function of at least two factors: the S-
phase fraction and the rate ofexfoliation ofbronchiolar
cells. Thus, the observed decreased LI can be inter-
preted in at least three different ways: a) DCM inhala-
tion suppressed replicative DNA synthesis ofbronchi-
olar epithelium for up to 26 weeks, b) DCM exposure
prolonged generation time (length of cell cycle) of
bronchiolar epithelium, or c) DCM induced selective
cell death (exfoliation) in the growth fraction so the
number oflabeled cells in the epithelial layer decreased
from that ofcontrol animals.
Mathematical simulations on bronchiolar cell turn-
over for the conditions a) and c) above are possible
under assumptions that a) the epithelial cell number
per unit length ofbasement membrane is constant and
the length ofthe cell cycle is constant in either control
or treated mice, b) the cell turnover rate oflabeled and
nonlabeled cells is same, and c) only aged cells (nonla-
beled cells in this situation) are exfoliating in the con-
trol mice. A simulation for DCM suppressing replica-
tive DNA synthesis shows that the 40-60% reduction
in LI over 6 days can be attributed directly to the
40-60% reduction in the size ofthe S-phase fraction, if
exfoliation in DCM-treated mice also occurs only in
nonlabeled cell population. A simulation for DCM
inducing selective cell death shows that up to a 50%
reduction in LI over 6 days can be attributed to the
selective killing effect of DCM without any changes in
the size of S-phase fraction. Although additional stud-
ies on cell-cycle dynamics are needed for definitive
interpretation of6-day pump data, the reality seems to
fall somewhere between these two extreme situations:
DCM probably suppressed replicative DNA synthesis
of the bronchiolar epithelium to a slight or moderate
degree.
By light microscopy, there was no obvious treat-
ment-related morphological change such as hyperpla-
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sia, atrophy, necrosis, or metaplasia in bronchiolar
regions up to 26 weeks. We also failed to detect signifi-
cant changes in LI and morphology of alveolar type-II
cells in the first 4 weeks of exposure to DCM (prelimi-
nary observation).
Lungs of mice exposed to 2000 ppm DCM up to 52
and 78 weeks had various lesions such as focal type-II
cell hyperplasia, alveolar/bronchiolar (A/B) tumors,
slight to moderate chronic inflammatory cell infiltra-
tion of the bronchi and bronchioles, and mucous meta-
plasia ofthe bronchial and bronchiolar epithelium (pre-
liminary observation).
Alveolar/bronchiolar tumors were observed in B6C3F1
mice inhaling 2000 and 4000 ppm DCM for up to 2 years
(1,14). Because the lung contains a heterogeneous cell
population, there has been considerable debate and
speculation on the cell oforigin ofmouse A/B neoplasia
(15-18). Morphological data implicate the type II cell
as the probable cell of origin of mouse A/B neoplasms,
especially when early time points are examined (19).
On the other hand, biochemical data, especially that
relating to metabolic and detoxification pathways,
implicate the Clara cell as a main metabolic site for
inhaled DCM in mouse lungs (2,20).
It was hoped that measurement of cell proliferation
would help resolve the mechanism oflung tumorinduc-
tion by DCM and give some indication ofthe cell ofori-
gin. Potent mouse pulmonary carcinogens have been
reported to induce initial suppression in DNA synthe-
sis in alveolar and bronchiolar epithelial cell popula-
tion, followed by usually more than a 100% increase in
cell proliferation (hyperplasia) within 4 weeks (21-24).
Our results on replicative DNA synthesis in lung cells
of DCM-exposed mice show a lack of such significant
enhancement in cell proliferation in the latent period,
suggesting that the mechanism of tumor induction by
DCM is not associated with significant enhancement
of cell proliferation. Further studies are necessary to
elucidate the cell of origin and mechanism of induction
ofDCM-induced lung tumors in B6C3F1 mice.
This work was supported in part by a grant from the Risk Science
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